Case 1:06-cv-00741-SLR
Document 38
Filed 04/25/2007
Page 1 of 3
Case 1:06-cv-00741-SLR
Document 38
Filed 04/25/2007
Page 2 of 3
Case 1:06-cv-00741-SLR
Document 38
Filed 04/25/2007
Page 3 of 3
Case 1:06-cv-00741-SLR
Document 38-2
Filed 04/25/2007
Page 1 of 1
UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
CELGENE CORPORATION, NOVARTIS ) PHARMACEUTICALS CORPORATION and )
NOVARTIS PHARMA A.G.,
)
Plaintiffs
v. ABRIKA PHARMACEUTICALS, INC., and ABRIKA PHARMACEUTICAL, LLLP,
)
)
) Civil Action No. 06-741 (SLR)
)
) )
Defendants.
)
)
ORDER
Upon consideration of Defendants' Rule 12(c) Motion for Judgment on the Pleadings, the Opening Brief in support of such motion and the opposition thereto, it is
hereby ordered and decreed that said motion is GRANTED.
As the sole basis for plaintiffs' allegation of willful infringement of U.S. Patent
No. 5,837,284 and U.S. Patent No. 6,635,284 (collectively, "the '284 patents") is defendants* submission of Abbreviated New Drug Application No. 78-458, and the mere filing of an AND A cannot, as a matter of law, support a finding of willful infringement,
the Court concludes that defendants have not willfully infringed the '284 patents.
IT IS SO ORDERED.
Dated:
Sue L. Robinson, U.S.D.J.
Case 1:06-cv-00741-SLR
Document 38-3
Filed 04/25/2007
Page 1 of 1